...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Therapeutic apheresis and dialysis: official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy >Two-Stage Basilic Vein Transposition: Second Stage Results
【24h】

Two-Stage Basilic Vein Transposition: Second Stage Results

机译：两阶段碱静脉转子：第二阶段结果

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

The increasing survival of hemodialysis patients results in the depletion of superficial venous capital justifying the use of the basilic vein. Many groups still prefer an arteriovenous graft due to transposition complexity and the time needed to achieve maturation. In this work we review the results of our series of basilic vein transpositions (BVT). BVTs were performed in two stages: first, creation of the fistula; second, transposition of the vein using three small incisions in the arm. All patients had to have direct arterialization of the basilic vein, therefore, patients with previous ipsilateral wrist fistulas also followed a two-stage protocol. Data were retrospectively revised from all transposition procedures made between September 2005 and November 2012. Patency and complication rates were the primary outcomes evaluated. A total of 276 basilic veins were transposed. Usage rate was 82.2%. 8% (N=22) of the fistulas were never used due to thrombosis. Secondary patency rates at 1 and 2 years were, respectively, 84% and 66.3%. Complications occurred in 61.6% (N=170) of fistulas and 65.9% (N=112) of which had to undergo surgical or endovascular revision. The most frequent complication was vein stenosis (39.7% of late complications, N=92). Albeit its greater technical complexity, the transposed basilic vein represents a hemodialysis access with good patency rates. Complication rates, although high, are less than those of CVC or prosthetic grafts. These results support the use of the transposed basilic vein as hemodialysis access after the brachiocephalic fistula.
机译：血液透析患者的增加生存导致浅表静脉资本的耗尽，证明碱静脉的使用。由于转置复杂性和实现成熟所需的时间，许多组仍然更喜欢动静脉移植物。在这项工作中，我们审查了我们系列的巨大静脉换位（BVT）的结果。 BVT分为两个阶段：首先，创建瘘管;其次，臂上使用三个小切口迁移静脉。所有患者必须具有直接动脉化碱静脉，因此，先前的同侧手腕瘘管也遵循两级方案。从2005年9月和2012年11月之间的所有转移程序回顾性修订了数据。Patens和并发症率是评估的主要结果。共转移了总共276个巨大静脉。使用率为82.2％。由于血栓形成，从未使用过8％（n = 22）的瘘管。分别为1和2年的二级通用率，分别为84％和66.3％。并发症发生在61.6％（n = 170）的瘘管中，其中65.9％（n = 112），其不得不经历外科或血管内修订。最常见的并发症是静脉狭窄（占后期并发症的39.7％，n = 92）。虽然其技术复杂性更大，但转置的粗静脉表示具有良好通用率的血液透析机。并发症率虽然高，但高于CVC或假体移植物。这些结果支持在肱骨瘘后使用转置的碱静脉作为血液透析接入。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号